Table 3.
Types and frequency of adverse events reported by participants.
| Number of Participants per Non-Invasive Neuromodulation Technique | ||||
|---|---|---|---|---|
| rTMS (N = 286) |
tDCS (N = 428) |
|||
| Type of Adverse Event | Active (n = 143) | Sham (n = 143) | Active (n = 220) | Sham (n = 208) |
| Headaches | 10 | 0 | 2 | 1 |
| Discomfort at Stimulation Side | 1 | 0 | 4 | 1 |
| Seizure | 0 | 1 | 0 | 0 |
| Heaviness of the Head | 0 | 1 | 0 | 0 |
| Tingling | 0 | 0 | 16 | 13 |
| Itchiness | 0 | 0 | 0 | 1 |
| Mood Changes | 0 | 0 | 0 | 1 |
| Total Number of Adverse Events | 11 | 2 | 22 | 17 |